Proton Therapy for Mediastinal Lymphoma (PROMLY)

Study acronym: PROMLY
StatusRecruiting
PhaseNot applicable
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
The study aims to investigate whether proton therapy is feasible in a national setting and whether proton therapy can reduce the risk of late toxicity (secondary cancers and heart toxicity) compared to foton therapy.
Trial Details
NCT Number NCT07817641
Lead Sponsor Copenhagen University Hospital, Rigshospitalet
Collaborators: Danish Centre for Particle Therapy, Aarhus University Hospital, Denmark, Aalborg University Hospital, Odense University Hospital
Conditions
(from sponsor)		 Mediastinal Lymphoma, Hodgkin Disease Lymphoma, Diffuse Large B Cell Lymphoma (DLBCL)
Related terms Hodgkin Disease, Lymphoma, Lymphoma, Large B-Cell, Diffuse
Enrollment 139 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov